Intracoronary infusion of mononuclear cells after PCI-treated myocardial infarction and arrhythmogenesis: is it safe?

To reduce long-term morbidity after revascularised acute myocardial infarction, different therapeutic strategies have been investigated. Cell therapy with mononuclear cells from bone marrow (BMMC) or peripheral blood (PBMC) has been proposed to attenuate the adverse processes of remodelling and subs...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Robbers, L. F. H. J., Nijveldt, R., Beek, A. M., Kemme, M. J. B., Delewi, R., Hirsch, A., van der Laan, A. M., van der Vleuten, P. A., Piek, J. J., Zijlstra, F., van Rossum, A. C.
Formato: Artigo
Idioma:Inglês
Publicado em: Bohn Stafleu van Loghum 2012
Assuntos:
ICIN
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3286504/
https://ncbi.nlm.nih.gov/pubmed/22351557
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12471-012-0251-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados